Semaglutide works by engaging natural pathways in the body that help regulate appetite, blood sugar, and digestion. When used under licensed medical supervision, it may support metabolic balance and sustainable weight management by:

• Supporting Insulin Function: Helping the body use insulin more effectively when blood sugar levels rise
• Reducing Glucagon Levels: Helping prevent excess glucose release from the liver
• Slowing Digestion: Promoting a longer feeling of fullness after meals
• Modulating Appetite Signals: Acting on receptors in the brain that influence hunger and food intake
• Supporting Pancreatic Function: Helping maintain healthy beta-cell activity

When prescribed and monitored by a licensed provider, semaglutide may support:

• Improved blood sugar control and lower fasting glucose levels
• Steadier energy and reduced post-meal fluctuations
• Clinically observed weight reduction in eligible patients
• Enhanced cardiometabolic health and cardiovascular protection
• A low risk of hypoglycemia when used appropriately

Individual results vary and are determined by your licensed medical provider based on your health profile, goals, and adherence to your treatment plan.

In clinical research settings, semaglutide has demonstrated the potential to support meaningful and sustainable weight reduction when used under licensed medical supervision. Reported findings from major studies have included:

• Average body-weight reduction of approximately 12–15% among participants receiving continuous medical care
• Sustained outcomes over extended follow-up periods (up to 68 weeks)
• Improvements in body composition and metabolic markers
• Reduction in visceral adiposity (abdominal fat)
• Support for long-term weight maintenance when combined with lifestyle guidance

Research Reference:

Clinical trials such as the STEP program observed that a majority of participants achieved at least a 5% reduction in body weight under medical supervision, with some achieving reductions of 15% or more.

These findings reflect results from controlled clinical studies and may not represent individual outcomes. Eligibility, treatment decisions, and results are determined by a licensed provider during a medical evaluation.

Semaglutide is available only by prescription and should be used under the supervision of a licensed medical provider. Before initiating therapy, your clinician will review your medical history, current medications, and any contraindications to determine eligibility and safety.

Commonly Reported Effects

When starting treatment, some individuals may experience mild or temporary side effects such as:

• Nausea or stomach discomfort
• Bloating or fullness
• Occasional constipation or diarrhea
• Dizziness or fatigue

These typically improve as the body adjusts. Any persistent or severe symptoms should be reported to the prescribing clinician promptly.

Who Should Avoid Semaglutide

Semaglutide is not appropriate for everyone. It may be contraindicated for individuals with:

• A personal or family history of medullary thyroid carcinoma (MTC) or MEN2 syndrome
• Known hypersensitivity to semaglutide or formulation ingredients
• Certain gastrointestinal conditions or pancreatitis history

Your licensed provider will determine if semaglutide is a safe option for you after reviewing your full health background.

Monitoring and Follow-Up

All patients are monitored throughout treatment to ensure proper dosing, safety, and effectiveness. Adjustments are made by the licensed medical provider based on individual progress and tolerance.

This information is provided for educational purposes only and should not be considered medical advice. All prescriptions, clinical decisions, and pharmacy fulfillment are handled exclusively by licensed medical professionals and U.S. pharmacies under the supervision of Dr. Crystal Broussard, MD (CA License C167102).